Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system - a Phase I minimization clinical trial

Biomedicine and Pharmacotherapy

Volumn 61, Issue 9 SPEC. ISS., 2007, Pages 588-590

  Yip, Adrian Y S ^a   Loo, Wings T Y ^a   Chow, Louis W C ^a  

^a UNIMED Medical Institute   (Hong Kong)

Author keywords

Hepatitis B surface antigen; Hepatitis B virus; Herbal medicine; Immunomodulatory; Monocyte

Indexed keywords

HERBACEOUS AGENT; KY 88; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FRUCTUS SCHISANDRAE; FRUIT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE INJURY; IMMUNITY; IMMUNOMODULATION; LEUKOCYTE; LIVER CELL; LIVER PROTECTION; LYMPHATIC SYSTEM; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PERIPHERAL VEIN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; WUWEIZI;

EID: 35248842743     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.08.018     Document Type: Article

References (17)

1. Maddrey W.C. Hepatitis B - an important public health issue. Clin Lab 47 (2001) 51-55
2. Ho C.F., Wong K.H., Chan C.W., Lee S.S., Chiu W.F., Ng Y.W., et al. Current pattern and course of acute hepatitis B virus infection in Hong Kong. J Gastroenterol Hepatol 19 5 (2004 May) 602-603
3. Department of Health. Surveillance of viral hepatitis in Hong Kong - 2003 update Report. [Cited 05 Jan 2005]. Available from URL: http://www.info.gov.hk/hepatitis/download/papers/hepsurv03.pdf.
4. Hilleman M.R. Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19 15-16 (2001 Feb 28) 1837-1848 (Review)
5. Chow L.W.C., Loo T.Y., and Sham J.S.T. Effects of a herbal compound containing bupleurum on human lymphocytes. Hong Kong Med J 7 (2001) 408-413
6. Li X.Y. Immunomodulating Chinese herbal medicines. Mem Inst Oswaldo Cruz 86 Suppl 2 (1991) 159S-164S
7. Ohtake N., Suzuki R., Daikuhara H., Nakai Y., Yamamoto M., Amagaya S., et al. Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to. Int J Immunopharmacol 22 6 (2000 Jun) 419-430
8. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 191 8 (2000) 1263-1268
9. Peakman M., and Vergani D. Basic and clinical immunology (2003), Churchill Livingstone p. 68-9
10. Lee W.M. Hepatitis B virus infection. N Eng J Med 337 (1997) 1733-1745
11. Seeger C., and Mason W.S. Hepatitis B virus biology. Micro Mol Biol Rev 64 (2000) 51-68
12. Chow W.C., Loo T.Y., and Sham S.T. Cytokine production by human lymphocytes stimulated by a herbal compound containing Bupleurum (KY88 LIVER LIVO). Acta Pharmacol Sin 24 2 (2003 Feb) 140-144
13. Lai C.L., Chien R.N., Leung N.W., Chang T.T., Guan R., Tai DI., et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339 2 (1998 Jul 9) 61-68
14. Lau K.K., Carman W.F., Locarnini S., Okuda K., Lu Z.M., Williams R., et al. Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective. J Gastroenterol Hepatol 14 (1999) 3-12
15. Malik A.H., and Lee W.M. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 132 (2000) 723-731
16. Liaw Y.F. Management of patients with chronic hepatitis B. J Gastroenterol Hepatol 17 (2002) 406-408
17. Lau G.K. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15 Suppl (2000 May) E46-E52